Kavanaugh AF - Search Results

1

Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis after treatment with a monoclonal antibody to CD54 (ICAM-1).

Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS. Schulze-Koops H, et al. Among authors: kavanaugh af. Clin Exp Immunol. 1996 Nov;106(2):190-6. doi: 10.1046/j.1365-2249.1996.d01-828.x. Clin Exp Immunol. 1996. PMID: 8918562 Free PMC article.

2

Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy.

Kavanaugh A, St Clair EW, McCune WJ, Braakman T, Lipsky P. Kavanaugh A, et al. J Rheumatol. 2000 Apr;27(4):841-50. J Rheumatol. 2000. PMID: 10782805 Clinical Trial.

3

Biologics in the treatment of rheumatoid arthritis: mechanisms of action.

Kavanaugh A, Lipsky P. Kavanaugh A, et al. Curr Dir Autoimmun. 2001;3:240-73. doi: 10.1159/000060525. Curr Dir Autoimmun. 2001. PMID: 11791469 Review. No abstract available.

4

Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones.

Kavanaugh AF, Lightfoot E, Lipsky PE, Oppenheimer-Marks N. Kavanaugh AF, et al. J Immunol. 1991 Jun 15;146(12):4149-56. J Immunol. 1991. PMID: 1710241

5

Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit.

Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS. Schulze-Koops H, et al. Among authors: kavanaugh af. J Immunol. 1995 Nov 15;155(10):5029-37. J Immunol. 1995. PMID: 7594511

6

Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis.

Davis LS, Kavanaugh AF, Nichols LA, Lipsky PE. Davis LS, et al. Among authors: kavanaugh af. J Immunol. 1995 Apr 1;154(7):3525-37. J Immunol. 1995. PMID: 7897232

7

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1.

Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, Lipsky PE. Kavanaugh AF, et al. Arthritis Rheum. 1994 Jul;37(7):992-9. doi: 10.1002/art.1780370703. Arthritis Rheum. 1994. PMID: 7912930 Clinical Trial.

8

A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis.

Kavanaugh AF, Davis LS, Jain RI, Nichols LA, Norris SH, Lipsky PE. Kavanaugh AF, et al. J Rheumatol. 1996 Aug;23(8):1338-44. J Rheumatol. 1996. PMID: 8856611 Clinical Trial.

9

Elevated cytokine messenger RNA levels in the peripheral blood of patients with rheumatoid arthritis suggest different degrees of myeloid cell activation.

Schulze-Koops H, Davis LS, Kavanaugh AF, Lipsky PE. Schulze-Koops H, et al. Among authors: kavanaugh af. Arthritis Rheum. 1997 Apr;40(4):639-47. doi: 10.1002/art.1780400408. Arthritis Rheum. 1997. PMID: 9125245

10

Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody.

Kavanaugh AF, Schulze-Koops H, Davis LS, Lipsky PE. Kavanaugh AF, et al. Arthritis Rheum. 1997 May;40(5):849-53. doi: 10.1002/art.1780400511. Arthritis Rheum. 1997. PMID: 9153545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters